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Extended-spectrum cephalosporin (ESC)-resistant Enterobacteriaceae is an increasingly
important problem in both human and veterinary medicine. The aims of this study
were to describe a comparative molecular characterization of Enterobacteriaceae
carrying ESC resistance genes, encoding extended-spectrum β-lactamase (ESBL) and
AmpC, isolated from human stool samples, rectal swabs from companion animals,
and swabs from the environment of veterinarian hospitals in South Korea, and to
examine their possible dissemination and transmission. The ESC resistance genes
were identified by PCR and sequencing. Isolates with the predominant ESC resistance
genes were assessed for their genetic relatedness by pulsed-field gel electrophoresis
(PFGE) and multi-locus sequence typing. A total of 195 Escherichia coli and 41
Klebsiella pneumoniae isolates that exhibited ESC resistance were recovered on
CHROMagar ESBL from human, companion animal, and the veterinary hospital
environmental samples. In companion animals, most of the ESC resistance genes
were blaCMY−2−like (26.4%), followed by blaCTX−M−55 (17.2%) and blaCTX−M−14 (16.1%),
whereas blaCTX−M−15 (28.6%) was predominant in human samples. The epidemiological
relatedness of isolates carrying ESC resistance genes, including 124 E. coli and 23
K. pneumoniae isolates carrying CMY-2-like, DHA-1-like, or/and CTX-M-type, were
analyzed by PFGE. The pulsotypes of five E. coli isolates (three from dogs and two
from humans) carrying blaCMY−2−like, which were attributed to sequence type 405,
from different veterinary clinics showed >85% similarity. Our results indicate direct
transmission and dissemination of ESC-resistant Enterobacteriaceae between humans
and companion animals.
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INTRODUCTION
The concept of “One Health,” which is the integration of human,
animal, environmental, and ecosystem health, has recently
emerged (Takashima and Day, 2014). One issue that should
be addressed through a One Health approach is antimicrobial
resistance (AMR). Therefore, we need to take steps to address
the dissemination of AMR through the adoption of a One Health
approach, promoting the integration of human and animal
health, food safety, and environmental surveillance (Roca et al.,
2015; Sikkema and Koopmans, 2016).
Enterobacteriaceae are among the most commonly reported
causes of bacterial infections in humans and animals (Schmiedel
et al., 2014). Notably, Enterobacteriaceae carrying extended-
spectrum β-lactamases (ESBLs) and AmpC β-lactamases
(AmpCs) are broadly distributed among extended-spectrum
cephalosporin (ESC)-resistant bacteria (Kameyama et al., 2013).
In both humans and animals, CTX-M-type enzymes are the most
common ESBLs, whereas CMY-, and DHA-type enzymes are the
most prevalent plasmid-mediated AmpCs (Liebana et al., 2004;
Jacoby, 2009; Matsumura et al., 2012). These enzymes are able
to inactivate ESCs and are normally encoded on mobile genetic
elements, thus they can be transmitted to the same or different
bacteria in humans, animals, foods, or the environment through
either directly (transmission of AMR bacteria), or indirectly
(transfer of AMR genes) (Haenni et al., 2014; Hong et al., 2016).
Companion animals could play a role as a reservoir of AMR
bacteria, as they are in close association with humans, living in
their homes, and near their food. In addition, the widespread use
and misuse of antibiotics in both human and veterinary medicine
is increasing the spread of AMR bacteria (Dorado-García et al.,
2018; Melo et al., 2018; Pulss et al., 2018). However, the impact of
companion animals on human health in terms of attributing to
exchange and share AMR determinant is not yet clear. Therefore,
systematic control and prevention, through implementation
of a national AMR surveillance program, are greatly needed
and should be applied in the fields of human, and veterinary
clinical medicine.
In this study, we represented a molecular characterization
of ESC-resistant Enterobacteriaceae isolates collected from
companion animals, humans, and veterinary hospital
environments as part of a national surveillance program at
36 veterinary hospitals in South Korea and examined their
epidemiological relatedness.
MATERIALS AND METHODS
Bacterial Profiles
We collected Escherichia coli and Klebsiella pneumoniae isolates
from the rectal swabs of companion animals, including dogs
(n = 315) and cats (n = 74); stool samples of humans, including
pet owners (n = 48) and medical staff (n = 33); and 352
swabs of veterinary hospital environmental surfaced, including
examination tables, cages, water bowls, scales, microscopes,
keyboards, and switches, at 36 veterinarian hospitals of various
regions in South Korea during July to November, 2017. All
samples were cultured on CHROMagar ESBL (CHROMagar,
Paris, France) for use in the selection of E. coli (dark pink to
reddish colony) and Klebsiella/Enterobacter/Citrobacter species
(metallic blue colony). After pure sub-culture for a single colony
on each blood agar plate (SPL Life Sciences, Gyeonggi-do,
South Korea) per a given sample, E. coli and K. pneumoniae
isolates were selected and identified by matrix-assisted laser
desorption ionization-time of flight mass spectrometry (MALDI-
TOF MS) with a Vitek-MS (bioMérieux, Marcy-l’Etoile, France).
Antimicrobial Susceptibility Testing
The isolates were tested for antimicrobial susceptibility to
the following antimicrobial agents: ampicillin, piperacillin,
ampicillin-sulbactam, cefazolin, cefoxitin, cefotaxime,
ceftazidime, cefepime, aztreonam, ertapenem, imipenem,
meropenem, amikacin, gentamicin, ciprofloxacin, and
trimethoprim-sulfamethoxazole, by the agar disk diffusion
method on Mueller-Hinton agar (Difco Laboratories, Detroit,
MI, United States) according to the guidelines of the Clinical
and Laboratory Standards Institute (CLSI, 2018b). The minimal
inhibitory concentration of colistin was determined by broth
microdilution using the criteria of the European Committee for
Antimicrobial Susceptibility Testing (EUCAST, 2018).
Detection of Antimicrobial Resistance
Genes
Template DNA was prepared by the boiling method. PCR and
DNA sequencing of various AMR genes, including
blaCTX−M−1 group, blaCTX−M−2 group, blaCTX−M−9 group,
blaCTX−M−25 group, blaTEM, blaSHV, blaDHA, blaCMY−1, blaCMY−2,
blaACC, blaACT, blaFOX, blaIMP, blaVIM, blaNDM, blaKPC, blaGES,
and blaOXA−48−like, were performed as described previously (Lee
et al., 2018a). The sequences were compared to published DNA
sequences using BLAST1.
ESBL/AmpC Production Phenotypic
Testing
ESC-resistant isolates with ESBL/AmpC PCR-negative were
performed phenotypic disk diffusion test to confirm for
ESBL/AmpC production (Song et al., 2007a,b).
Nucleotide Sequence-Based Bacterial
Typing
The epidemiological relationships among the CTX-M-type
or/and CMY-2-like-producing isolates, which being collected
from humans, companion animals, and the environment, were
analyzed by pulsed-field gel electrophoresis (PFGE) using XbaI
restriction enzyme. Then after, multilocus sequence typing
(MLST) was performed for E. coli and K. pneumoniae strains with
representative PFGE profiles as described previously (Nemoy
et al., 2005; Jeong et al., 2016). E. coli ATCC 25922 and
K. pneumoniae ATCC 13883 were included as quality controls.
1https://blast.ncbi.nlm.nih.gov/Blast.cgi
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Statistical Analysis
Statistical analysis was performed using SPSS Statistics version
24.0.0 (IBM Corp., Armonk, NY, United States). For comparison
of the ESC-resistance rates between groups, we used the chi-
square test. All p values were two-sided, and values less than 0.05
were considered statistically significant.
RESULTS
ESC Resistance and Antimicrobial
Susceptibility
Among 389 samples of companion animals (315 dogs and 74
cats), 81 of humans (48 owners and 33 staffs), and 352 of
veterinary hospital environmental surface, a total of 236 non-
duplicated ESC-resistant isolates, including 195 E. coli, and
41 K. pneumoniae isolates were recovered. There were some
cases that both ESC-resistant E. coli and K. pneumoniae isolates
were simultaneously selected from 17 dogs, one cat, and one
the environmental sample (Supplementary Table S1). Of the
195 ESC-resistant E. coli isolates, 174 (44.7%) were recovered
from companion animals (389 total samples), 14 (17.3%) were
recovered from human stool samples (81 total samples), and 7
(2%) were recovered from the environment (352 total samples).
Among the E. coli isolates from companion animals, the ESC-
resistance rate for canines (49.2%) was significantly higher
than the rate for feline isolates (25.7%) (p value = <0.001).
Of the 41 ESC-resistant K. pneumoniae isolates, 29 (7.5%)
were recovered from companion animals, and 12 (3.4%) were
recovered from the environment. Among the K. pneumoniae
isolates from companion animals, the ESC-resistance rate for
canines (8.3%) was not statistically different from the rate of
felines (4.1%) (p value = 0.216). None were recovered from
human-derived samples (Table 1). The AMR profiles of the
ESC-resistant E. coli and K. pneumoniae isolates are listed
in Supplementary Tables S2, S3, respectively.
Genotypes of ESC Resistance
We performed genotype characterization of ESC resistance for
all ESC-non-susceptible 195 E. coli and 41 K. pneumoniae
isolates, regardless of isolation of both E. coli and K. pneumoniae
isolates in same sample. Among the ESC-non-susceptible 195
E. coli, 171 (87.7%) isolates harbored known ESC resistance
genes (Table 1), including nine different ESBL types and
four AmpC types. A few isolates harbored both ESBL and
AmpC (seven isolates carried CTX-M-type and CMY-2-like
genes, and one isolate carried CTX-M-type and DHA-1-like
genes). Of the 174 ESC-resistant E. coli isolates categorized
from companion animals, blaCMY−2−like gene (n = 46, 26.4%)
was most common ESC resistance determinant, followed by
CTX-M-55 (n = 30, 17.2%), CTX-M-14 (n = 28, 16.1%), and
CTX-M-15 (n = 20, 11.5%), which were the dominant ESBL
genes. Interestingly, for the ESC-resistant E. coli isolates in
companion animals, NDM-5 was detected in four isolates along
with blaCTX−M−15 and blaCMY−2−like. Of the 14 ESC-resistant
E. coli isolates from humans, CTX-M-15 was predominant,
which accounted for 28.6% of the total (n = 4). One isolate
was positive for SHV-190, and remaining 24 isolates were
negative for both known ESBLs and AmpCs by the primers
used in this study.
Among the ESC-non-susceptible 41 K. pneumoniae isolates,
six different ESBL types and three AmpC types were detected
in all 41 (100%) isolates (Table 1). In samples from companion
animals and the environment, CTX-M-15 (n = 25) and DHA-
1-like (n = 21) were dominant genotypes, followed by SHV-
types (n = 5), and CTX-M-14 (n = 5). The presence of both
ESBL- and AmpC-type genes was detected in 21 K. pneumoniae
isolates (51.2%), and in 8 E. coli isolates (4.1%). No ESC-
resistant K. pneumoniae isolates were recovered from human
stool samples (Table 1).
Macro-Restriction of ESC-Resistant
Enterobacteriaceae
To determine the epidemiological relatedness among ESC-
resistant isolates from companion animals, humans, and various
hospital areas in veterinarian clinics, 124 E. coli and 23
K. pneumoniae isolates carrying the predominant ESC resistance
genes (E. coli carrying CTX-M-15, CTX-M-55, CTX-M-14,
or/and CMY-2-like genes, and K. pneumoniae carrying CTX-M-
15 or/and DHA-1-like genes) were subjected to PFGE analysis.
Among the 124 E. coli isolates, similar PFGE patterns were
observed only between isolates from companion animals and
humans (Supplementary Figure S1). Five CMY-2-like harboring
E. coli isolates without other resistance genes belonged to
one pulsotype, with >85% similarity, which was attributed to
sequence type 405 (ST405) by MLST analysis. Three of the five
isolates were derived from samples obtained at the same hospital,
two were from humans (E246 was from a veterinarian and E249
was from a nurse) and the third was from a rectal swab from a
dog (E245) admitted to the above hospital. The two remaining
isolates (E92 and E118) were collected from two dogs at different
veterinary clinics (Figure 1). For the 23 K. pneumoniae isolates
that mostly produced CTX-M-15 or/and DHA-1-like enzymes
in companion animals and the environment, 7 pulsotypes were
identified which corresponded to ST307 (d, e, and f PFGE-
types), ST392 (a, b, and c PFGE-types), and ST950 (g PFGE-
type) (Figure 2).
DISCUSSION
Antimicrobial resistance surveillance systems of clinical isolates
in South Korea have been well-documented in both the Korea
antimicrobial resistance monitoring system (KARMS) and Korea
global antimicrobial surveillance system (Kim et al., 2017;
Lee et al., 2018b). However, this is the first report on the
prevalence and molecular characterization of ESC-resistant
Enterobacteriaceae isolates collected from companion animals,
humans, and the veterinarian hospital environment for national
surveillance in South Korea. Previously, the KARMS study
for human clinical isolates reported that the rate of AMR to
cefotaxime was 35.0% in E. coli and 41.0% in K. pneumoniae (Kim
et al., 2017). Among the E. coli isolates collected from rectal swabs
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of dogs and cats obtained in this study, the rates of ESBL- or/and
AmpC-producing E. coli isolates were 43.5% (137/315) for dogs
and 24.3% (18/74) for cats, respectively. In previous study showed
that the rate of ESBL or/and AmpC-producing E. coli isolates in
dogs had a 38.1% (So et al., 2012), which represented currently
increasing incidence in South Korea.
CTX-M type ESBL genes in the fields of human medicine, and
CMY type AmpC genes in both human and veterinary medicine,
are dominant in E. coli worldwide including South Korea
(Kameyama et al., 2013; Lee et al., 2018a). Especially, CTX-M-
15- and CMY-2-producing E. coli isolates are the most frequently
detected genotypes associated with ESC resistance in companion
TABLE 1 | Genotypes of β-lactamases in extended-spectrum cephalosporin-resistant E. coli and K. pneumoniae isolates from companion animals, humans, and the
hospital environment.
Organism ESC resistance genea No. (%) isolates
ESBLb AmpC Carbapenemase Companion animal Human
(n = 81)
Environment
(n = 352)
Total
(n = 822)
Dog(n = 315) Cat
(n = 74)
E. coli CTX-M-1 3 1 0 0 4
CTX-M-3 4 0 0 1 5
CTX-M-15 11 1 4 0 16
CTX-M-15 CMY-2-like NDM-5 4 0 0 0 4
CTX-M-55 26 1 0 0 27
CTX-M-55
+ CTX-M-14
0 1 0 0 1
CTX-M-55 CMY-2-like 2 0 0 0 2
CTX-M-14 25 2 1 1 29
CTX-M-14 CMY-2-like 1 0 0 0 1
CTX-M-14 DHA-1-like 1 0 0 0 1
CTX-M-24 3 2 0 0 5
CTX-M-27 5 1 2 0 8
CTX-M-65 6 1 0 0 7
SHV-190 1 0 0 0 1
CMY-2-like 40 6 2 3 51
CMY-2-like+ DHA-1-like 0 2 0 0 2
CMY-4 1 0 0 0 1
DHA-1-like 3 0 2 0 5
DHA-9 1 0 0 0 1
Unidentified Unidentified Unidentified 18 1 3 2 24
Total 155 (49.2) 19 (25.7) 14 (17.3) 7 (2.0) 195 (23.7)
K. pneumoniae CTX-M-15 10 1 0 1 12
CTX-M-15 DHA-1-like 6 0 0 6 12
CTX-M-15
+ CTX-M-14
DHA-1-like 1 0 0 0 1
CTX-M-55 DHA-1-like 0 0 0 1 1
CTX-M-55 DHA-9 0 0 0 1 1
CTX-M-14 2 0 0 1 3
SHV-12 DHA-1-like 2 0 0 2 4
SHV-26 DHA-1-like 2 0 0 0 2
SHV-28 1 0 0 0 1
CMY-2-like 1 1 0 0 2
DHA-1-like 0 1 0 0 1
CMY-2-like + DHA-1-like 1 0 0 0 1
Total 26 (8.3) 3 (4.1) 0 (0) 12 (3.4) 41 (5.0)
aESC, extended-spectrum cephalosporin.bESBL, extended-spectrum β-lactamase.
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FIGURE 1 | Pulsed-field gel electrophoresis (PFGE) dendrogram of the five CMY-2-like producing E. coli ST405 (This image was modified for illustrative purposes).
Owner-566 is a veterinarian in the hospital C-26. Staff-570 is a nurse in the hospital C-26. M, metropolitan region; C, central region; S, southern region.
FIGURE 2 | Epidemiological profiles of 23 K. pneumoniae isolates carrying ESC resistance gene (CTX-M-15 and DHA-1-like) determined by PFGE analysis using
XbaI restriction. Environment-1, examining table; Environment-2, cage; Environment-4, scale; Environment-7, keyboard; Environment-8, switch; M, metropolitan
region; C, central region; S, southern region.
animals and humans, respectively (Matsumura et al., 2012;
Woerther et al., 2013; Haenni et al., 2014; Dorado-García et al.,
2018). Because companion animals are in close contact with
humans, the genotypes of companion animals in this study were
initially expected to be similar to the genotypes of humans
disseminated in South Korea. The total number of CMY-2-like-
producing E. coli isolates was greater than the number of CTX-
M-type (CTX-M-55-, CTX-M-14, and CTX-M-15)-producing
isolates from the rectal swabs of companion animals, which was
consistent with the numbers described in previous reports of
AmpC in animals, suggesting that it is an important mechanism
of resistance to ESC (So et al., 2012; Dorado-García et al.,
2018). Instead, CTX-M-15 was more detected than other ESC-
resistant determinants in humans, but CTX-M-55 and CTX-M-
14 were more prevalent than CTX-M-15 in companion animals
in this study. The CTX-M-55 and CTX-M-14 were previously
detected in food-producing animals and turkey meat, respectively
(Kiratisin et al., 2008; Randall et al., 2011; Matsumura et al., 2012;
Liao et al., 2015). These findings indicate that the ESC resistance
gene variants are not limited to certain hosts, emphasizing the
need for coordinated control in the concept of One Health.
In addition, in previous studies, CTX-M-14 were the most
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common ESC resistance genotypes, whereas CTX-M-55 was
rarely detected in companion animals in South Korea (So et al.,
2012; Tamang et al., 2012). Therefore, the observed increase in
CTX-M-55 in companion animals in South Korea may also affect
AMR transmission between humans and companion animals.
All 41 ESC-resistant K. pneumoniae isolates harbored ESC-
resistance genes. In contrast, of the 195 ESC-resistant E. coli
isolates, 24 (12.3%) isolates did not identify for ESBL, and/or
AmpC type in this study. These isolates were susceptible to
cefoxitin and were positive for ESBL production (disk diffusion
test), suggesting the presence of an ESBL variant not detected
by the primers used in this study. We performed PFGE to
understand the relatedness between ESC-resistant E. coli and
K. pneumoniae isolates from humans, companion animals,
and the environment in veterinary hospitals during 5 months.
Most of the ESC-resistant isolates had no evidence of clonal
spread between humans and companion animals. Instead,
the five CMY-2-producing E. coli ST405 isolates from two
humans and three dogs showed high identity, which suggested
the possibility of direct transmission between humans, and
companion animals. The spread of E. coli ST405 carrying
CTX-M-15 has been frequently described in humans as an
epidemic lineage, along with E. coli ST131 (Coque et al.,
2008). However, we detected E. coli ST405 carrying CMY-2-like
genes in this study.
In this study, CTX-M-15 (61.0%, n = 25/41), either alone
or in combination with DHA-1-like, was mostly detected in
ESC-resistant K. pneumoniae isolates from companion animals
and the environmental samples. Recently, CTX-M-15- and
DHA-1-coproducing K. pneumoniae ST11 have emerged in
human patients and are being disseminated (Cha et al.,
2018; Lee et al., 2018a), while there was no report that
described in K. pneumoniae isolate carrying CTX-M-15 from
dogs and cats in South Korea. CTX-M-15 was essentially
associated with ST11, ST15, ST307, and ST392 clones in
K. pneumoniae, which have been frequently detected in other
part of the world (Ewers et al., 2014; Wyres et al., 2019).
ST307 is also frequent among carbapenemase producers in
South Korea, suggesting a wider dissemination in different
setting in our country (Yoon et al., 2018a,b). There was no
transmission between humans and companion animals, however,
clonal spread was observed among companion animals and
between companion animals and the environment in this study.
Based on the observation of environmental colonization of
AMR K. pneumoniae in veterinary hospitals, infection control
for the environment should be carefully considered in the
veterinary field.
Our results have limitations: (i) the number of stool specimens
from humans was less than that of companion animals and
the isolation of ESBL/AmpC producing K. pneumoniae was
unusually more frequent than E. coli with ESBL/AmpC in the
environmental samples. Unfortunately, we do not know the
reason why for this, (ii) plasmid distribution was not included in
this study, which is well known to contribute to ESBL distribution
in Enterbacteriaceae. Nevertheless, our findings illustrate the
importance of infection control strategies for usage of antibiotics
and demonstrate the need for further cooperation among the
fields of human and veterinary medicine and environmental
science in the One Health perspective.
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TABLE S2 | Antimicrobial susceptibilities of extended-spectrum
cephalosporin-resistant E. coli isolates from humans, companion animals, and the
hospital environment.
TABLE S3 | Antimicrobial susceptibilities of extended-spectrum
cephalosporin-resistant K. pneumoniae isolates from companion animals and the
hospital environment.
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